Isomerase Awarded French Research Tax Credit Accreditation (CIR)

August 4th, 2015—Cambridge

 

Isomerase Therapeutics Limited, a leader in Synthetic Biology of Therapeutic Agents and Bioengineering of Microbial Natural Products, is delighted to announce that it has received approval under the French Research Tax Credit scheme for the period 2015-2017.

 

The French Ministry of Research ((La Ministère de L’Education nationale de l'Enseignement supérieur et de la Recherche, MENESR)) approved the "Crédit d’Impôt Recherche" (CIR) accreditation for Isomerase in July 2015. This initiative is offered by the French Government and allows eligible French research companies, which are subject to corporate tax in France, to claim significant tax relief on costs incurred by R & D activities outsourced to Isomerase.

Dr Matt Gregory, CEO of Isomerase remarked: "We are delighted to see that the French Ministry of Research recognises the innovative research we are able to carry out in collaboration with our partners. This approval will enable Isomerase to more effectively support R&D with current and future partners from France."

If you would like to get in touch with Isomerase to discuss how we can support your research and development, please contact Lesley Sheehan or Matt Gregory via our contact page.

For additional information on the CIR Research Tax Credit please see http://www.enseignementsup-recherche.gouv.fr